Multiple Myeloma Hub cover image

Integrating BCMA-directed agents in the treatment landscape for relapsed/refractory MM

Multiple Myeloma Hub

CHAPTER

Exploring Progress in BCMA-based Therapies and Combination Treatments

Exploring the effectiveness of BCMA-based agents in treating keratopathy, focusing on positive responses in combination therapies, especially with Belantimab Maffordoten. Discussions include high response rates, keratopathy management concerns, potential of bi-specifics, and personalized treatment strategies based on patient eligibility and response.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner